| |
| Names | |
|---|---|
| IUPAC name
[(2S,3R,4R)-Flavan-3,3′,4′,5,7-pentol]-(2-oxy-7,8→4)-[(2R,3R,4S)-flavan-3,3′,4′,5-tetrol]-(4→8)-[(2R,3R)-flavan-3,3′,4′,5,7-pentol] | |
| Systematic IUPAC name
(2R,3R,4S,8S,14R,15R)-2,8-Bis(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-8-yl]-3,4-dihydro-2H,8H,14H-8,14-methanobenzo[d]pyrano[2,3-h][1,3]benzodioxocine-3,5,11,13,15-pentol | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider |
|
PubChem CID |
|
| UNII | |
| |
| |
| Properties | |
| C45H36O18 | |
| Molar mass | 864.75 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Cinnamtannin B1 is a condensed tannin found in Cinnamomum verum. It falls under the category of type A proanthocyanidin.[1]
Cinnamon could potentially exhibit pharmacological effects in treating type 2 diabetes mellitus and insulin resistance. The plant material predominantly employed in the study was sourced from Chinese cinnamon (see Chinese cinnamon's medicinal uses).[2][3] Recent phytochemical research has suggested that cinnamtannin B1, extracted from C. Verum, might have a potential therapeutic impact on type 2 diabetes,[4] with the exception of postmenopausal patients studied using Cinnamomum aromaticum.[5]
Cinnamtannin B1 possesses multiple phenolic hydroxyl groups and is noted for its antioxidant properties, antimicrobial activities, and ability to inhibit platelet aggregation,[6][7] which could contribute to the protection of damaged tissues in wounds.[7]
This article incorporates text from this source, which is available under the CC BY 4.0 license.
|
Types of procyanidins
| |
|---|---|
| A-type proanthocyanidins |
|
| B type proanthocyanidins |
|
| Types |
|
